Valent BioSciences
Valent BioSciences Hosts Sustainability Celebration at Osage Facility
Broadening its commitment to sustainability, Valent BioSciences formally dedicated a new prairie park and solar field adjacent to its manufacturing facility.
Valent BioSciences CEO Ted Melnik to Retire
Salman Mir, currently Executive Vice President and Chief Operating Officer, has been named President and CEO, also effective July 2023.
Valent BioSciences Acquires Biorationals Firm FBSciences
Acquisition strengthens Valent BioSciences’ participation in the rapidly growing $3.5 billion global biostimulant market.
Solar Field at Valent BioSciences’ Osage Facility Is Now Operational
The new solar field at Valent BioSciences’ manufacturing facility in Osage, Iowa, is now fully operational. Testing over […]
Valent BioSciences Launches New Biostimulant Operating Unit
The new biostimulant business team is focused on discovering, developing, and commercializing arbuscular mycorrhizal fungi (AMF) products.
Valent BioSciences Announces Major Expansion at Its Osage Facility
Expansion will help meet increasing demand for its biorational products and the introduction of new products requiring more capacity.
Biological Insecticide from Valent BioSciences Approved for Bacterial Disease Management
LEAP ES delivers two-way protection from both bacterial diseases and lepidopteran larvae that can reduce crop quality and yield.
Valent BioSciences, Kansas State Sign Collaborative Agreement for Soil Health Research Initiative
The agreement will advance critical research in soil health and carbon smart farming with Distinguished Professor of Soil Microbiology, Dr. Charles W. Rice.